M&A Deal Summary

AngioDynamics Acquires Navilyst Medical

On January 31, 2012, AngioDynamics acquired healthcare services company Navilyst Medical from Avista Capital Partners for 372M USD

Acquisition Highlights
  • This is AngioDynamics’ 1st transaction in the Healthcare Services sector.
  • This is AngioDynamics’ largest (disclosed) transaction.
  • This is AngioDynamics’ 5th transaction in the United States.

M&A Deal Summary
Date 2012-01-31
Target Navilyst Medical
Sector Healthcare Services
Buyer(s) AngioDynamics
Sellers(s) Avista Capital Partners
Deal Type Add-on Acquisition
Deal Value 372M USD

Target

Navilyst Medical

Marlborough, United States
website
Navilyst Medical, Inc. is a provider of innovative solutions for image-guided interventions delivering superior outcomes and reducing healthcare costs for medical professionals and their patients.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

AngioDynamics

Latham, New York, United States

website

Category Company
Founded 1988
Sector Medical Products
Employees760
Revenue 316M USD (2022)
DESCRIPTION

AngioDynamics is a provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics was incorporated in 1988 and is based in Latham, New York.

DEAL STATS #
Overall 5 of 9
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 4 of 8
Country (United States) 5 of 8
Year (2012) 1 of 2
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-12 FlowMedica

Fremont, California, United States

FlowMedica, Inc. manufactures intravascular systems for implementing Targeted Renal Therapy.

Buy $2M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-08 Vortex Medical

Norwell, Massachusetts, United States

Vortex Medical, Inc. is a medical device company focused on the design, development and commercialization of novel endomechanical devices for the endovascular market.

Buy -

Seller(S) 1

SELLER

Avista Capital Partners

New York, New York, United States

website

Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

DEAL STATS #
Overall 9 of 30
Sector (Healthcare Services) 2 of 3
Type (Add-on Acquisition) 5 of 15
Country (United States) 7 of 24
Year (2012) 2 of 4
Size (of disclosed) 8 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-01-31 BioReliance

Rockville, Maryland, United States

BioReliance provides critical services that include biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics, and other life science customers worldwide.

Sell $350M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-05-02 Fougera Pharmaceuticals

Melville, New York, United States

Fougera Pharmaceuticals Inc. operates two primary divisions in the US focused on specialty pharmaceuticals in dermatology: Fougera, its generic dermatology medicines business, and PharmaDerm, its branded dermatology business. Founded in 1849, the Fougera division is the leading manufacturer and distributor of a wide range of topical products. The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body.

Sell $1.5B
Mergr

Product

Company

Legal